Unknown

Dataset Information

0

ErmB determinants and Tn916-Like elements in clinical isolates of Clostridium difficile.

ABSTRACT: Erythromycin and tetracycline resistance was analyzed in 37 Clostridium difficile clinical isolates. Strains of different clonal origins showed different erythromycin and tetracycline resistance determinants and different genetic arrangements of the elements. In strains of recent isolation, the presence of Tn916-like elements, never found before in C. difficile clinical isolates, has been demonstrated.

SUBMITTER: Spigaglia P 

PROVIDER: S-EPMC1140533 | biostudies-literature | 2005 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

ErmB determinants and Tn916-Like elements in clinical isolates of Clostridium difficile.

Spigaglia Patrizia P   Carucci Valentina V   Barbanti Fabrizio F   Mastrantonio Paola P  

Antimicrobial agents and chemotherapy 20050601 6

Erythromycin and tetracycline resistance was analyzed in 37 Clostridium difficile clinical isolates. Strains of different clonal origins showed different erythromycin and tetracycline resistance determinants and different genetic arrangements of the elements. In strains of recent isolation, the presence of Tn916-like elements, never found before in C. difficile clinical isolates, has been demonstrated. ...[more]

Similar Datasets

Unknown Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
| S-EPMC2493101 | biostudies-literature
Unknown Characterization of Bacteriophages Infecting Clinical Isolates of <i>Clostridium difficile</i>.
| S-EPMC6079236 | biostudies-literature
Unknown Variation in germination of Clostridium difficile clinical isolates correlates to disease severity.
| S-EPMC4467518 | biostudies-literature
Unknown The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.
| S-EPMC4038106 | biostudies-literature
Unknown Behavior and target site selection of conjugative transposon Tn916 in two different strains of toxigenic Clostridium difficile.
| S-EPMC3302608 | biostudies-literature
Unknown Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile.
| S-EPMC7196352 | biostudies-literature
Unknown Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.
| S-EPMC4681371 | biostudies-literature
Unknown Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
| S-EPMC3318759 | biostudies-literature
Unknown Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile.
| S-EPMC5367918 | biostudies-literature
Unknown Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan.
| S-EPMC5115699 | biostudies-literature